DHX9 and central nervous system cancer: DHX9 silencing decreased the expression of colony‐stimulating factor 1 (CSF1), which partially restored the inhibitory effect on malignant progress of glioma and infiltration of TAMs caused by DHX9 knockdown by targeting the transcription factor 12 (TCF12).